Stephanie A. Haddad, DO (@drsahaddad) 's Twitter Profile
Stephanie A. Haddad, DO

@drsahaddad

Hem/Onc Fellow @UTHealthSAMDA |IM’24 @BrownUniversity|WVSOM'21 @WVSOM|Holy Cross'15 @holy_cross|Breast Oncology. Medicine. Research. Fitness. Views are my own.

ID: 1406084378816548869

calendar_today19-06-2021 03:00:51

660 Tweet

677 Followers

1,1K Following

Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

Good to be back at Women Leaders in Oncology (WLO) & Allies - with a powerhouse panel & moving tribute to ally-ship by Clifford Hudis Never too late for you to join us in support of Conquer Cancer, the ASCO Foundation– WLO Endowed YIA (YIA) ASCO #ASCO25 fundraise.givesmart.com/form/Gj3spw?vi…

Good to be back at Women Leaders in Oncology (WLO) &amp; Allies - with a powerhouse panel &amp; moving tribute to ally-ship by <a href="/CliffordHudis/">Clifford Hudis</a>
Never too late for you to join us in support of <a href="/ConquerCancerFd/">Conquer Cancer, the ASCO Foundation</a>– WLO Endowed YIA (YIA) <a href="/ASCO/">ASCO</a> #ASCO25 

fundraise.givesmart.com/form/Gj3spw?vi…
ASCO (@asco) 's Twitter Profile Photo

We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗

OncoDaily (@oncodaily) 's Twitter Profile Photo

Does scalp cooling work to prevent alopecia with T-DXd? - Paolo Tarantino (Paolo Tarantino) oncodaily.com/insight/306438 #ASCO2025 #ASCO25 #breastcancer #scalpcooling #Cancer #Oncology #OncoDaily #Health #Medicine #MedEd #MedTwitter CancerWorld

Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Dato-DXd is the latest ADC to be approved for treating HR+/HER2- MBC, joining two other topo1 ADCs (T-DXd, SG). How should we sequence these agents? We polled physicians from the Dana-Farber’s Breast Oncology Center group. The resulting consensus is now published, here: physicianresources.dana-farber.org/flexpaper/dato…

Dato-DXd is the latest ADC to be approved for treating HR+/HER2- MBC, joining two other topo1 ADCs (T-DXd, SG). How should we sequence these agents? We polled physicians from the <a href="/DFCI_BreastOnc/">Dana-Farber’s Breast Oncology Center</a> group. The resulting consensus is now published, here: physicianresources.dana-farber.org/flexpaper/dato…
ASCO (@asco) 's Twitter Profile Photo

Missed ASCO25? #ASCOEdBook provides the latest updates in clinical care, authored by ASCO ed session faculty. Learn more: brnw.ch/21wTbv2

Missed ASCO25? #ASCOEdBook provides the latest updates in clinical care, authored by ASCO ed session faculty. Learn more: brnw.ch/21wTbv2
Supriya peshin (@supriyadocc) 's Twitter Profile Photo

Still recouping from the ASCO fever 💫 Grateful for the late-night laughs, deep conversations, and powerful moments at the Women in Oncology session. Surrounded by inspiring colleagues who are also cherished friends this is what fuels the future of oncology. 💪💖 #ASCO25

Still recouping from the ASCO fever 💫
Grateful for the late-night laughs, deep conversations, and powerful moments at the Women in Oncology session.
Surrounded by inspiring colleagues who are also cherished friends this is what fuels the future of oncology. 💪💖
#ASCO25